[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety & Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE). I4V-MC-JAIM

Upstate Institutional Review Board (IRB) Number:

1676409

Study/Protocol ID:

I4V-MC-JAIM

Patient Age Group:

Adults

Principal Investigator:

Andras Perl, MD, PhD

Who can I contact for more information?

Name: Joanne M Chilton, CCRP
Phone: 315-464-8240
Email: chiltonj@upstate.edu

Return to Previous Page || Search Again

Top